Carlsmed Inc CARL
$12.59
▼ -0.55%
($-0.07)
🎈 Low Float
📅 Earnings This Week
Open
$12.66
Prev Close
$12.66
Day Range
$12.31 – $12.87
52W Range
$8.50 – $17.19
Market Cap
$342.26M
Beta
2.14
EPS (TTM)
$-1.31
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2025-07-23 |
| Shares Out. | 27,180,000 |
| Website | carlsmed.com/ ↗ |
| Phone | 13022880670 |
| Employees | 127 |
| Revenue | $16.1M |
| Gross Profit | $12.4M |
| Net Income | -$8.7M |
| Free Cash Flow | -$35.7M |
| Total Assets | $118.8M |
| Total Liabilities | $26.5M |
| Equity | $92.2M |
About Carlsmed Inc
Carlsmed Inc is a commercial-stage medical technology company focused on developing AI-enabled personalized solutions for spine surgery. The company operates as a single operating and reportable segment engaged in the design, manufacture, and marketing of its Aprevo technology platform, which provides customized surgical planning and implants for lumbar and cervical spine fusion procedures, mainly sold to hospitals and ambulatory surgical centers.
Carlsmed Inc is a publicly traded company under the ticker symbol CARL on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
11 analysts (2026-07-01)